Self-expanding stents for recanalization of acute cerebrovascular occlusions

American Journal of Neuroradiology

Volumn 28, Issue 5, 2007, Pages 816-822

  Levy, Elad I ^a,b   Mehta, R ^a   Gupta, R ^e   Hanel, R A ^a,b   Chamczuk, A J ^a   Fiorella, D ^c   Woo, H H ^c   Albuquerque, F C ^d   Jovin, T G ^e   Horowitz, M B ^e   Hopkins, L N ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d BARROW NEUROLOGICAL INSTITUTE   (United States)

^e PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CONVENTIONAL ANGIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INTERNAL CAROTID ARTERY; MALE; MIDDLE CEREBRAL ARTERY; MORTALITY; OCCLUSIVE CEREBROVASCULAR DISEASE; RECANALIZATION; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; STENT; STROKE; THROMBOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CEREBRAL ANGIOGRAPHY; CEREBRAL REVASCULARIZATION; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RETROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME; VERTEBROBASILAR INSUFFICIENCY;

EID: 34248634329     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-11
2. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke 2004;35:2848-54
3. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-38
4. Eckert B, Koch C, Thomalla G, et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 2005;36:1160-65
5. Gupta R, Vora NA, Horowitz MB, et al. Multimodal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke 2006;37:986-90
6. Gupta R, Jovin TG, Tayal A, et al. Urgent stenting of the M2 (superior) division of the middle cerebral artery after systemic thrombolysis in acute stroke. AJNR Am J Neuroradiol 2006;27:521-23
7. Levy EI, Ecker RD, Horowitz MB, et al. Stent-assisted intracranial recanalization for acute stroke: early results. Neurosurgery 2006;58:458-63
8. Levy EI, Ecker RD, Hand RA, et al. Acute M2 bifurcation stenting for cerebral infarction: lessons learned from the heart. Technical case report. Neurosurgery 2006;58:E588
9. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:322-28
10. Summary of Safety and Probable Benefit: Wingspan Stent System with Gateway PTA Balloon Catheter. Available at: http://www.fda.gov/cdrh/pdf5/ h050001b.pdf. Accessed February 27, 2006.
11. Henkes H, Miloslavski E, Lowens S, et al. Treatment of intracranial atherosclerotic stenoses with balloon dilatation and self-expanding stent deployment (WingSpan). Neuroradiology 2005;47:222-28
12. Sauvageau E, Levy EI. Self-expanding stent-assisted middle cerebral artery recanalization: technical note. Neuroradiology 2006;48:405-08
13. Levy EI, Sauvageau E, Hanel RA, et al. Self-expanding versus balloon-mounted stent-assisted recanalization following embolic occlusion in the canine model: technical feasibility study. AJNR Am J Neuroradiol 2006;27:2069-72
14. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/ IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994;330:956-61
15. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. The EPILOG Investigators. N Engl J Med 1997;336:1689-96
16. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study [published erratum appears in Lancet 1997;350:744]. Lancet 1997;349:1429-35
17. ESPRIT Investigators. Enhanced Suppression of the Platelet II/IIIa Receptor with Integrum Therapy. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial [published erratum appears in Lancet 2001;357:1370]. Lancet 2000;356:2037-44
18. Steinhubl SR, Talley JD, Braden GA, et al. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation 2001;103:2572-78
19. Walter DH, Schachinger V, Eisner M, et al. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 1997;350:1217-19
20. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932-36
21. Higashida R, Furlan A, Roberts H, et al. Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. J Vasc Interv Radiol 2003;14:S493-S494
22. Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003;34:e109-137
23. Sheehan FH, Braunwald E, Canner P, et al. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation 1987;75:817-29
24. Lincoff AM, Topol EJ. Illusion of reperfusion. Does anyone achieve optimal reperfusion during acute myocardial infarction? Circulation 1993;88:1361-74
25. Ringer AJ, Qureshi AI, Fessler RD, et al. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery 2001;48:1282-90
26. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. AJNR Am J Neuroradiol 2006;27:1177-82
27. Levy EI, Hanel RA, Howington JU, et al. Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response. J Neurosurg 2004;100:688-94
28. Levy EI, Hanel RA, Tio FO, et al. Safety and pharmacokinetics of sirolimus-eluting stents in the canine cerebral vasculature: 180-day assessment. Neurosurgery 2006;59:925-33; discussion 933-4
29. Smith S. for the Multi-MERCI Investigators. Results of the Multi-MERCI trial (abstract P503). Stroke 2006;37:711-12
30. Fiorella D, Albuquerque FC, Deshmukh VR, et al. In-stent stenosis as a delayed complication of Neuroform stent-supported coil embolization of an incidental carotid terminus aneurysm. AJNR Am J Neuroradiol 2004;25:1764-67